Skip to content

Weight in Lower Limbs Improves Gait Ataxia of in Machado-Joseph Disease Patients

Weight in Lower Limbs Improves Gait Ataxia Of in Machado-Joseph Disease Patients: A Randomized Crossover Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02906046
Enrollment
20
Registered
2016-09-19
Start date
2012-04-30
Completion date
2014-07-31
Last updated
2016-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Machado-Joseph Disease

Keywords

SCA 3, Ataxic Gait

Brief summary

Few studies evaluated the efficacy of adding weights on the lower limbs in patients with ataxic disorders. There is no current evidence on which would be the most appropriate weight for use in this context. To assess progress and benefits of using this load, gait of symptomatic carriers of spinocerebellar ataxia type 3/Machado Joseph disease the objective of the study is to evaluate the gait with and without different load weights on lower limbs. Outcomes were the Scale for the Assessment and Ataxia Rating of (SARA), kinematic gait assessment by the accelerometer and gyroscope and the Patient Global Impression (PGI) about which weight they prefer for walking.

Interventions

DEVICEWeight in Lower Limbs

Sponsors

Federal University of Health Science of Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients should have between 18 and 65 years of age and independent gait

Exclusion criteria

* Were the need of assistive devices for walking ≤ 10m (such as crutches, wheelchairs and orthotics) * Item gait of Scale for the Assessment and Rating of Ataxia (SARA)19≥, presence of other neurological disease that affect motor system * Orthopedic impairments of lower limbs (fractures or surgeries in the past 6 months) * Difference between the lower limbs greater than 3.0 cm

Design outcomes

Primary

MeasureTime frame
Gait speed analysis [speed (mt/min) of walking for 10 meters away]speed (mt/min) of walking for 10 meters away in 1min timeout

Secondary

MeasureTime frame
Gait cadence analysis [cadence (steps/min) of walking for 10 meters away]cadence (steps/min) of walking for 10 meters away in 1min timeout

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026